What is a stock summary page? Click here for an overview.
Business Description
Centogene NV
NAICS : 621512
SIC : 8099
ISIN : NL0014040206
Share Class Description:
STU:39K: Ordinary SharesDescription
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.32 | |||||
| 9-Day RSI | 39.34 | |||||
| 14-Day RSI | 44.59 | |||||
| 3-1 Month Momentum % | -46.49 | |||||
| 6-1 Month Momentum % | -42.75 | |||||
| 12-1 Month Momentum % | -74.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -70.11 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-Revenue | 1.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Centogene NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 48.536 | ||
| EPS (TTM) (€) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.49 | ||
| 3-Year Sortino Ratio | -0.82 | ||
| Volatility % | 167.57 | ||
| 14-Day RSI | 44.59 | ||
| 14-Day ATR (€) | 0.043244 | ||
| 20-Day SMA (€) | 0.2355 | ||
| 12-1 Month Momentum % | -74.55 | ||
| 52-Week Range (€) | 0.08 - 1.255 | ||
| Shares Outstanding (Mil) | 29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Centogene NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Centogene NV Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Centogene NV Frequently Asked Questions
What is Centogene NV(STU:39K)'s stock price today?
The current price of STU:39K is €0.18. The 52 week high of STU:39K is €1.25 and 52 week low is €0.08.
When is next earnings date of Centogene NV(STU:39K)?
The next earnings date of Centogene NV(STU:39K) is 2025-04-07 Est..
Does Centogene NV(STU:39K) pay dividends? If so, how much?
Centogene NV(STU:39K) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers